USA - Einstein researchers develop novel antibiotics that don't trigger resistance

In a study described in Nature Chemical Biology, researchers from Albert Einstein College of Medicine of Yeshiva University in Bronx, N.Y., are developing a new generation of antibiotic compounds that do not provoke bacterial resistance. The compounds work against two notorious microbes: Vibrio cholerae, which causes cholera, and Escherichia coli O157:H7, the food contaminant that causes approximately 110,000 illnesses and 50 deaths each year in the U.S.